China Pioneer Pharma Holdings Ltd

Price Chart

Risk-Adjusted Performance

China Pioneer Pharma Holdings Ltd (1345) Price Performance

China Pioneer Pharma Holdings Ltd (1345) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at HKD2.27, up 1.34% from the previous close.

Over the past year, 1345 has traded between a low of HKD1.68 and a high of HKD2.37. The stock has gained 15.0% over this period. It is currently 35.1% above its 52-week low.

China Pioneer Pharma Holdings Ltd has a market capitalization of $2.67B, with a price-to-earnings ratio of 23.00 and a dividend yield of 4.83%.

About China Pioneer Pharma Holdings Ltd

Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People's Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, dental devices, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; medical research and experimental development; and provision of metal finishing services. It sells its products to hospitals, medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.